Response to Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide—Should Consideration Be Given to Cannalicular Efflux Transporters?

Documenti analoghi

• Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide: Should Consideration Be Given to Cannalicular Efflux Transporters?
  di: Srinivas, NR
  Pubblicazione: (2015)
• Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
  di: Hopkins, AM, et al.
  Pubblicazione: (2015)
• Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis
  di: Hopkins, Ashley M., et al.
  Pubblicazione: (2015)
• An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors
  di: Fuentealba, Rodrigo A., et al.
  Pubblicazione: (2012)
• Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide
  di: Terekhova, Irina, et al.
  Pubblicazione: (2020)